Wednesday, 19 March 2014 10:54

Anticoagulation news items. Week commencing 10th March 2014

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

European Heart Journal

This 3-yr study (n=8709 on zotarolimus-eluting stent [ES]/sirolimus-ES) suggests dual antiplatelet therapy (DAPT) use influenced rate of stent thrombosis to a different extent, depending upon type of implanted DES; and optimal duration of DAPT will likely depend upon stent type.

 

The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service.
Further details on this service can be found at: http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services